Physician profile
Sapan Sharankishor Desai
NPI 1700088234
$1,171,154.86
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1.2M · 2020: $1,890.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,164,528.59 | 2019-2020 | |
| Boston Scientific Corporation | $5,639.44 | 2019-2020 | |
| Cardiovascular Systems INC. | $384.69 | 2019 | |
| Lemaitre Vascular, INC. | $137.77 | 2019-2020 | |
| Cook Medical LLC | $87.39 | 2020 | |
| Tactile Systems Technology INC | $76.62 | 2019 | |
| Silk Road Medical, INC. | $53.44 | 2019 | |
| Csl Behring | $50.44 | 2019 | |
| Abbott Laboratories | $48.67 | 2020 | |
| Terumo Medical Corporation | $43.45 | 2019 | |
| Tei Biosciences INC | $27.52 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.64 | 2019 | |
| Medtronic Vascular, INC. | $21.22 | 2019 | |
| Bard Peripheral Vascular, INC. | $17.86 | 2020 | |
| Ekos Corporation | $14.12 | 2019 |
Research and ownership
$175,000.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sapan Desai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.